GoKawiilAnthropic's Claude AI flags novel CRISPR-like enzyme, scientists urge caution
Anthropic reported that its Claude AI system, running 950 agents over roughly 21 hours, sifted through about 200,000 reverse transcriptase samples and identified a previously unseen CRISPR-like enzyme system. Human scientists later confirmed the enzyme was genuinely novel, with MIT and Broad Institute professor Feng Zhang calling the RNA-repeat arrays linked to reverse transcriptases 'genuinely intriguing' and worthy of further study. Anthropic says human involvement was limited to prompting the AI and conducting lab verification.
GoKawiil's interpretation of the reporting above, not reported fact.
The claim highlights how AI systems could accelerate early-stage biological discovery by rapidly scanning public genomic databases for patterns humans might take months to find. However, outside scientists quoted in the coverage stop short of calling it a breakthrough, suggesting the finding still needs substantial follow-up research before its scientific or practical value is clear. This tempered response reflects broader questions about whether AI-driven 'discoveries' represent genuine scientific advances or promising but preliminary leads.
- Claude AI scanned ~200,000 reverse transcriptase samples in about 21 hours using 950 agents.
- Human scientists confirmed the enzyme system as previously unobserved, but caution it needs further study.
- The case raises broader questions about how much credit AI deserves versus human verification in scientific discovery.
Source: cnet.com — Joe Hindy, 2026-09-28
Published there as: “Did Anthropic Really Make a Big Biology Breakthrough? We Asked Scientists to Weigh In”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.